Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant

1 Dec 2022

Abstract excerpt

This study investigates early cardiac events (ECEs) occurring during the first 180 days after allogeneic hematopoietic cell transplant (allo-HCT) in 416 adults receiving posttransplant cyclophosphamide (PTCY) (n = 258) or not receiving PTCY (n = 158). Total body irradiation (TBI) was given to 133 (31.9%) patients, of whom 111 (83.4%) received TBI combined with PTCY. The day +180 cumulative incidence function...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Childhood Cancer Survivors' Quality of Life
Share to Hematopoietic Stem Cell Transplantation
Share to Renal Transplantation Outcomes and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36453637
DOI: 10.1182/bloodadvances.2022008792

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplantPMID 36453637Read ↗

Predictors of Late Cardiovascular Complications in Survivors of Hematopoietic Cell TransplantationSemantic proximity Read ↗

Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic TransplantationSemantic proximity Read ↗

Cardiovascular disease after hematopoietic cell transplantation - lessons learnedSemantic proximity Read ↗

A decade of experience using ATG and PTCy for graft‐versus‐host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantationSemantic proximity Read ↗

Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantationSemantic proximity Read ↗

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory studySemantic proximity Read ↗

The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.Semantic proximity Read ↗

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantationSemantic proximity Read ↗

Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-Leukemia Effects via HLA-B Leader in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation.Semantic proximity Read ↗

Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationSemantic proximity Read ↗

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factorsSemantic proximity Read ↗

Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.